The global cannabidiol market is expected to reach USD 22.05 billion by 2030. The market is expected to expand at a CAGR of 15.8% from 2024 to 2030. Changing consumer attitudes towards CBD products, shifting public opinion, and growing recognition of the health benefits of cannabidiol are some of the main factors contributing to the market's growth. The cannabis Sativa plant contains more than 80 cannabinoids, but cannabidiol is the most widely used for medical purposes because of its lack of psychoactive effects. It is primarily obtained from hemp due to its high CBD content. ![Global Cannabidiol Market]( "Global Cannabidiol Market")
There is a high demand for various CBD-infused products, such as beauty products, cannabis oil, beverages, gummies, capsules, etc. CBD can enter the human body through different means, including vaping, smoking, and through the skin. In the U.S., where cannabis is legal, CBD is utilized to produce personal care products and medical drugs. Legalizing cannabis-based products has opened up significant opportunities for various end-use industries to expand their product offerings.
Major players in the industry are focused on introducing CBD-infused products. Companies are exploring opportunities in international markets as the demand for CBD grows globally. Furthermore, they are investing in research and development to enhance the effectiveness and efficiency of their products, as well as to expand their offerings. The players are introducing new and innovative products, such as edibles, topicals, and beverages, to cater to the growing demand. For instance, in May 2022, Medical Marijuana, Inc. announced the launch of a pharma subsidiary in Brazil named “HM Pharma” to expand its access to CBD products in pharmacies.
There is a high demand for various CBD-infused products, such as beauty products, cannabis oil, beverages, gummies, capsules, etc. CBD can enter the human body through different means, including vaping, smoking, and through the skin. In the U.S., where cannabis is legal, CBD is utilized to produce personal care products and medical drugs. Legalizing cannabis-based products has opened up significant opportunities for various end-use industries to expand their product offerings.
Major players in the industry are focused on introducing CBD-infused products. Companies are exploring opportunities in international markets as the demand for CBD grows globally. Furthermore, they are investing in research and development to enhance the effectiveness and efficiency of their products, as well as to expand their offerings. The players are introducing new and innovative products, such as edibles, topicals, and beverages, to cater to the growing demand. For instance, in May 2022, Medical Marijuana, Inc. announced the launch of a pharma subsidiary in Brazil named “HM Pharma” to expand its access to CBD products in pharmacies.
Cannabidiol Market Report Highlights
- North America accounts for the largest with a market share of 87.4% in 2023 owing to the presence of major manufacturers, and approval of the U.S. Farm Bill are some of the major factors driving the growth of the region
- Hemp-derived CBD dominated the market in 2023, with a market share owing to its higher purity and potential health benefits
- B2B segment accounts for the largest market share in 2023 owing to increasing demand and a rising number of businesses using cannabidiol as raw materials
- In 2023, the pharmaceuticals segment accounted for the largest market share in the end-use market owing to rising use of cannabis derivate for various medical conditions
Table of Contents
Chapter 1. Cannabidiol Market: Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Source type
1.2.2. Sales type
1.2.3. End use
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
1.2. Segment Definitions
1.2.1. Source type
1.2.2. Sales type
1.2.3. End use
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Cannabidiol Market: Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Source type outlook
2.2.2. Sales type outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
2.2. Segment Outlook
2.2.1. Source type outlook
2.2.2. Sales type outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Cannabidiol Market: Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Cannabis Regulatory Scenario, by Country
3.2.1. U.S.
3.2.1.1. Cultivation/Production
3.2.1.2. Legal Status (CBD & THC)
3.2.1.3. Regulatory Bodies Involved
3.2.2. Canada
3.2.2.1. Cultivation/Production
3.2.2.2. Legal Status (CBD & THC)
3.2.2.3. Regulatory Bodies Involved
3.2.3. Germany
3.2.3.1. Cultivation/Production
3.2.3.2. Legal Status (CBD & THC)
3.2.3.3. Regulatory Bodies Involved
3.2.4. Italy
3.2.4.1. Cultivation/Production
3.2.4.2. Legal Status (CBD & THC)
3.2.4.3. Regulatory Bodies Involved
3.2.5. Croatia
3.2.5.1. Cultivation/Production
3.2.5.2. Legal Status (CBD & THC)
3.2.5.3. Regulatory Bodies Involved
3.2.6. Netherlands
3.2.6.1. Cultivation/Production
3.2.6.2. Legal Status (CBD & THC)
3.2.6.3. Regulatory Bodies Involved
3.2.7. Czech Republic
3.2.7.1. Cultivation/Production
3.2.7.2. Legal Status (CBD & THC)
3.2.7.3. Regulatory Bodies Involved
3.2.8. Poland
3.2.8.1. Cultivation/Production
3.2.8.2. Legal Status (CBD & THC)
3.2.8.3. Regulatory Bodies Involved
3.2.9. Switzerland
3.2.9.1. Cultivation/Production
3.2.9.2. Legal Status (CBD & THC)
3.2.9.3. Regulatory Bodies Involved
3.2.10. Australia
3.2.10.1. Cultivation/Production
3.2.10.2. Legal Status (CBD & THC)
3.2.10.3. Regulatory Bodies Involved
3.2.11. Israel
3.2.11.1. Cultivation/Production
3.2.11.2. Legal Status (CBD & THC)
3.2.11.3. Regulatory Bodies Involved
3.2.12. Uruguay
3.2.12.1. Cultivation/Production
3.2.12.2. Legal Status (CBD & THC)
3.2.12.3. Regulatory Bodies Involved
3.2.13. Colombia
3.2.13.1. Cultivation/Production
3.2.13.2. Legal Status (CBD & THC)
3.2.13.3. Regulatory Bodies Involved
3.2.14. Argentina
3.2.14.1. Cultivation/Production
3.2.14.2. Legal Status (CBD & THC)
3.2.14.3. Regulatory Bodies Involved
3.2.15. Chile
3.2.15.1. Cultivation/Production
3.2.15.2. Legal Status (CBD & THC)
3.2.15.3. Regulatory Bodies Involved
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Cannabidiol Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
3.5. Import/Export Scenario, by Country
3.5.1. U.S.
3.5.2. Canada
3.5.3. Germany
3.5.4. Italy
3.5.5. France
3.5.6. Croatia
3.5.7. Netherlands
3.5.8. Czech Republic
3.5.9. Poland
3.5.10. Switzerland
3.5.11. Uruguay
3.5.12. Columbia
3.5.13. Brazil
3.5.14. Argentina
3.5.15. Chile
3.5.16. Australia
3.5.17. China
3.5.18. India
3.5.19. Japan
3.5.20. New Zealand
3.5.21. South Korea
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Cannabis Regulatory Scenario, by Country
3.2.1. U.S.
3.2.1.1. Cultivation/Production
3.2.1.2. Legal Status (CBD & THC)
3.2.1.3. Regulatory Bodies Involved
3.2.2. Canada
3.2.2.1. Cultivation/Production
3.2.2.2. Legal Status (CBD & THC)
3.2.2.3. Regulatory Bodies Involved
3.2.3. Germany
3.2.3.1. Cultivation/Production
3.2.3.2. Legal Status (CBD & THC)
3.2.3.3. Regulatory Bodies Involved
3.2.4. Italy
3.2.4.1. Cultivation/Production
3.2.4.2. Legal Status (CBD & THC)
3.2.4.3. Regulatory Bodies Involved
3.2.5. Croatia
3.2.5.1. Cultivation/Production
3.2.5.2. Legal Status (CBD & THC)
3.2.5.3. Regulatory Bodies Involved
3.2.6. Netherlands
3.2.6.1. Cultivation/Production
3.2.6.2. Legal Status (CBD & THC)
3.2.6.3. Regulatory Bodies Involved
3.2.7. Czech Republic
3.2.7.1. Cultivation/Production
3.2.7.2. Legal Status (CBD & THC)
3.2.7.3. Regulatory Bodies Involved
3.2.8. Poland
3.2.8.1. Cultivation/Production
3.2.8.2. Legal Status (CBD & THC)
3.2.8.3. Regulatory Bodies Involved
3.2.9. Switzerland
3.2.9.1. Cultivation/Production
3.2.9.2. Legal Status (CBD & THC)
3.2.9.3. Regulatory Bodies Involved
3.2.10. Australia
3.2.10.1. Cultivation/Production
3.2.10.2. Legal Status (CBD & THC)
3.2.10.3. Regulatory Bodies Involved
3.2.11. Israel
3.2.11.1. Cultivation/Production
3.2.11.2. Legal Status (CBD & THC)
3.2.11.3. Regulatory Bodies Involved
3.2.12. Uruguay
3.2.12.1. Cultivation/Production
3.2.12.2. Legal Status (CBD & THC)
3.2.12.3. Regulatory Bodies Involved
3.2.13. Colombia
3.2.13.1. Cultivation/Production
3.2.13.2. Legal Status (CBD & THC)
3.2.13.3. Regulatory Bodies Involved
3.2.14. Argentina
3.2.14.1. Cultivation/Production
3.2.14.2. Legal Status (CBD & THC)
3.2.14.3. Regulatory Bodies Involved
3.2.15. Chile
3.2.15.1. Cultivation/Production
3.2.15.2. Legal Status (CBD & THC)
3.2.15.3. Regulatory Bodies Involved
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Cannabidiol Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
3.5. Import/Export Scenario, by Country
3.5.1. U.S.
3.5.2. Canada
3.5.3. Germany
3.5.4. Italy
3.5.5. France
3.5.6. Croatia
3.5.7. Netherlands
3.5.8. Czech Republic
3.5.9. Poland
3.5.10. Switzerland
3.5.11. Uruguay
3.5.12. Columbia
3.5.13. Brazil
3.5.14. Argentina
3.5.15. Chile
3.5.16. Australia
3.5.17. China
3.5.18. India
3.5.19. Japan
3.5.20. New Zealand
3.5.21. South Korea
Chapter 4. Cannabidiol Market: Source Type Estimates & Trend Analysis
4.1. Source Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Cannabidiol Market by Source Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Hemp
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Marijuana
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.2. Segment Dashboard
4.3. Global Cannabidiol Market by Source Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Hemp
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Marijuana
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Cannabidiol Market: Sales Type Estimates & Trend Analysis
5.1. Sales Type Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Cannabidiol Market by Sales Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Business to Business (B2B)
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Business to Consumer (B2C)
5.4.2.1. Hospital Pharmacies
5.4.2.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.2. Online Stores
5.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.3. Retail Stores
5.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.2. Segment Dashboard
5.3. Global Cannabidiol Market by Sales Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Business to Business (B2B)
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Business to Consumer (B2C)
5.4.2.1. Hospital Pharmacies
5.4.2.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.2. Online Stores
5.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.3. Retail Stores
5.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Cannabidiol Market: End Use Estimates & Trend Analysis
6.1. End Use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Cannabidiol Market by End Use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Medical
6.4.1.1. Chronic Pain
6.4.1.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.1.2. Mental Disorders
6.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.1.3. Cancer
6.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.1.4. Others
6.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.2. Personal Use
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Pharmaceutical
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.4. Wellness
6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.4.2. Food & Beverages
6.4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.4.3. Personal Care & Cosmetics
6.4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.4.4. Nutraceuticals
6.4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.4.5. Others
6.4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.2. Segment Dashboard
6.3. Global Cannabidiol Market by End Use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Medical
6.4.1.1. Chronic Pain
6.4.1.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.1.2. Mental Disorders
6.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.1.3. Cancer
6.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.1.4. Others
6.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.2. Personal Use
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Pharmaceutical
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.4. Wellness
6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.4.2. Food & Beverages
6.4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.4.3. Personal Care & Cosmetics
6.4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.4.4. Nutraceuticals
6.4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.4.5. Others
6.4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD million)
Chapter 7. Cannabidiol Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework
7.5.1.3. Competitive Scenario
7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Competitive Scenario
7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework
7.6.1.3. Competitive Scenario
7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Competitive Scenario
7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework
7.6.3.3. Competitive Scenario
7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework
7.6.4.3. Competitive Scenario
7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.6.5. Switzerland
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework
7.6.5.3. Competitive Scenario
7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.6.6. The Netherlands
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework
7.6.6.3. Competitive Scenario
7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.6.7. Poland
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework
7.6.7.3. Competitive Scenario
7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.6.8. Czech Republic
7.6.8.1. Key country dynamics
7.6.8.2. Regulatory framework
7.6.8.3. Competitive Scenario
7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.6.9. Croatia
7.6.9.1. Key country dynamics
7.6.9.2. Regulatory framework
7.6.9.3. Competitive Scenario
7.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Asia-Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework
7.7.1.3. Competitive Scenario
7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework
7.7.2.3. Competitive Scenario
7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework
7.7.3.3. Competitive Scenario
7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework
7.7.4.3. Competitive Scenario
7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.5. South Korea
7.7.5.1. Key country dynamics
7.7.5.2. Regulatory framework
7.7.5.3. Competitive Scenario
7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.7.6. New Zealand
7.7.6.1. Key country dynamics
7.7.6.2. Regulatory framework
7.7.6.3. Competitive Scenario
7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework
7.8.1.3. Competitive Scenario
7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.8.2. Mexico
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework
7.8.2.3. Competitive Scenario
7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.8.3. Argentina
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework
7.8.3.3. Competitive Scenario
7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.8.4. Colombia
7.8.4.1. Key country dynamics
7.8.4.2. Regulatory framework
7.8.4.3. Competitive Scenario
7.8.4.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.8.5. Uruguay
7.8.5.1. Key country dynamics
7.8.5.2. Regulatory framework
7.8.5.3. Competitive Scenario
7.8.5.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.8.6. Chile
7.8.6.1. Key country dynamics
7.8.6.2. Regulatory framework
7.8.6.3. Competitive Scenario
7.8.6.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Regulatory framework
7.9.1.3. Competitive Scenario
7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.9.2. Israel
7.9.2.1. Key country dynamics
7.9.2.2. Regulatory framework
7.9.2.3. Competitive Scenario
7.9.2.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework
7.5.1.3. Competitive Scenario
7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Competitive Scenario
7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework
7.6.1.3. Competitive Scenario
7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Competitive Scenario
7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework
7.6.3.3. Competitive Scenario
7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework
7.6.4.3. Competitive Scenario
7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.6.5. Switzerland
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework
7.6.5.3. Competitive Scenario
7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.6.6. The Netherlands
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework
7.6.6.3. Competitive Scenario
7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.6.7. Poland
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework
7.6.7.3. Competitive Scenario
7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.6.8. Czech Republic
7.6.8.1. Key country dynamics
7.6.8.2. Regulatory framework
7.6.8.3. Competitive Scenario
7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.6.9. Croatia
7.6.9.1. Key country dynamics
7.6.9.2. Regulatory framework
7.6.9.3. Competitive Scenario
7.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Asia-Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework
7.7.1.3. Competitive Scenario
7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework
7.7.2.3. Competitive Scenario
7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework
7.7.3.3. Competitive Scenario
7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework
7.7.4.3. Competitive Scenario
7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.5. South Korea
7.7.5.1. Key country dynamics
7.7.5.2. Regulatory framework
7.7.5.3. Competitive Scenario
7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.7.6. New Zealand
7.7.6.1. Key country dynamics
7.7.6.2. Regulatory framework
7.7.6.3. Competitive Scenario
7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework
7.8.1.3. Competitive Scenario
7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.8.2. Mexico
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework
7.8.2.3. Competitive Scenario
7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.8.3. Argentina
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework
7.8.3.3. Competitive Scenario
7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.8.4. Colombia
7.8.4.1. Key country dynamics
7.8.4.2. Regulatory framework
7.8.4.3. Competitive Scenario
7.8.4.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.8.5. Uruguay
7.8.5.1. Key country dynamics
7.8.5.2. Regulatory framework
7.8.5.3. Competitive Scenario
7.8.5.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.8.6. Chile
7.8.6.1. Key country dynamics
7.8.6.2. Regulatory framework
7.8.6.3. Competitive Scenario
7.8.6.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Regulatory framework
7.9.1.3. Competitive Scenario
7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.9.2. Israel
7.9.2.1. Key country dynamics
7.9.2.2. Regulatory framework
7.9.2.3. Competitive Scenario
7.9.2.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, by Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. ENDOCA
8.3.1.1. Company news
8.3.1.2. Financial performance
8.3.1.3. Product benchmarking
8.3.1.4. Strategic initiatives
8.3.2. Cannoid, LLC
8.3.2.1. Company news
8.3.2.2. Financial performance
8.3.2.3. Product benchmarking
8.3.2.4. Strategic initiatives
8.3.3. Medical Marijuana, Inc.
8.3.3.1. Company news
8.3.3.2. Financial performance
8.3.3.3. Product benchmarking
8.3.3.4. Strategic initiatives
8.3.4. Folium Europe B.V.
8.3.4.1. Company news
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Canopy Growth Corporation
8.3.5.1. Company news
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Elixinol
8.3.6.1. Company news
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. NuLeaf Naturals, LLC
8.3.7.1. Company news
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Isodiol International, Inc.
8.3.8.1. Company news
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. PharmaHemp
8.3.9.1. Company news
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. The Cronos Group
8.3.10.1. Company news
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. ENDOCA
8.3.1.1. Company news
8.3.1.2. Financial performance
8.3.1.3. Product benchmarking
8.3.1.4. Strategic initiatives
8.3.2. Cannoid, LLC
8.3.2.1. Company news
8.3.2.2. Financial performance
8.3.2.3. Product benchmarking
8.3.2.4. Strategic initiatives
8.3.3. Medical Marijuana, Inc.
8.3.3.1. Company news
8.3.3.2. Financial performance
8.3.3.3. Product benchmarking
8.3.3.4. Strategic initiatives
8.3.4. Folium Europe B.V.
8.3.4.1. Company news
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Canopy Growth Corporation
8.3.5.1. Company news
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Elixinol
8.3.6.1. Company news
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. NuLeaf Naturals, LLC
8.3.7.1. Company news
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Isodiol International, Inc.
8.3.8.1. Company news
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. PharmaHemp
8.3.9.1. Company news
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. The Cronos Group
8.3.10.1. Company news
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 North America cannabidiol market, by region, 2018-2030 (USD Million)
Table 3 North America cannabidiol market, by source type, 2018-2030 (USD Million)
Table 4 North America cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 5 North America cannabidiol market, by end use, 2018-2030 (USD Million)
Table 6 U.S. cannabidiol market, by source type, 2018-2030 (USD Million)
Table 7 U.S. cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 8 U.S. cannabidiol market, by end use, 2018-2030 (USD Million)
Table 9 Canada cannabidiol market, by source type, 2018-2030 (USD Million)
Table 10 Canada cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 11 Canada cannabidiol market, by end use, 2018-2030 (USD Million)
Table 12 Europe cannabidiol market, by region, 2018-2030 (USD Million)
Table 13 Europe cannabidiol market, by source type, 2018-2030 (USD Million)
Table 14 Europe cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 15 Europe cannabidiol market, by end use, 2018-2030 (USD Million)
Table 16 Germany cannabidiol market, by source type, 2018-2030 (USD Million)
Table 17 Germany cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 18 Germany cannabidiol market, by end use, 2018-2030 (USD Million)
Table 19 UK cannabidiol market, by source type, 2018-2030 (USD Million)
Table 20 UK cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 21 UK cannabidiol market, by end use, 2018-2030 (USD Million)
Table 22 France cannabidiol market, by source type, 2018-2030 (USD Million)
Table 23 France cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 24 France cannabidiol market, by end use, 2018-2030 (USD Million)
Table 25 Italy cannabidiol market, by source type, 2018-2030 (USD Million)
Table 26 Italy cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 27 Italy cannabidiol market, by end use, 2018-2030 (USD Million)
Table 28 Switzerland cannabidiol market, by source type, 2018-2030 (USD Million)
Table 29 Switzerland cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 30 Switzerland cannabidiol market, by end use, 2018-2030 (USD Million)
Table 31 Poland cannabidiol market, by source type, 2018-2030 (USD Million)
Table 32 Poland cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 33 Poland cannabidiol market, by end use, 2018-2030 (USD Million)
Table 34 The Netherlands cannabidiol market, by source type, 2018-2030 (USD Million)
Table 35 The Netherlands cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 36 The Netherlands cannabidiol market, by end use, 2018-2030 (USD Million)
Table 37 Czech Republic cannabidiol market, by source type, 2018-2030 (USD Million)
Table 38 Czech Republic cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 39 Czech Republic cannabidiol market, by end use, 2018-2030 (USD Million)
Table 40 Croatia cannabidiol market, by source type, 2018-2030 (USD Million)
Table 41 Croatia cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 42 Croatia cannabidiol market, by end use, 2018-2030 (USD Million)
Table 43 Asia-Pacific cannabidiol market, by region, 2018-2030 (USD Million)
Table 44 Asia-Pacific cannabidiol market, by source type, 2018-2030 (USD Million)
Table 45 Asia-Pacific cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 46 Asia-Pacific cannabidiol market, by end use, 2018-2030 (USD Million)
Table 47 China cannabidiol market, by source type, 2018-2030 (USD Million)
Table 48 China cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 49 China cannabidiol market, by end use, 2018-2030 (USD Million)
Table 50 Japan cannabidiol market, by source type, 2018-2030 (USD Million)
Table 51 Japan cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 52 Japan cannabidiol market, by end use, 2018-2030 (USD Million)
Table 53 India cannabidiol market, by source type, 2018-2030 (USD Million)
Table 54 India cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 55 India cannabidiol market, by end use, 2018-2030 (USD Million)
Table 56 South Korea cannabidiol market, by source type, 2018-2030 (USD Million)
Table 57 South Korea cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 58 South Korea cannabidiol market, by end use, 2018-2030 (USD Million)
Table 59 Australia cannabidiol market, by source type, 2018-2030 (USD Million)
Table 60 Australia cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 61 Australia cannabidiol market, by end use, 2018-2030 (USD Million)
Table 62 New Zealand cannabidiol market, by source type, 2018-2030 (USD Million)
Table 63 New Zealand cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 64 New Zealand cannabidiol market, by end use, 2018-2030 (USD Million)
Table 65 Latin America cannabidiol market, by source type, 2018-2030 (USD Million)
Table 66 Latin America cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 67 Latin America cannabidiol market, by end use, 2018-2030 (USD Million)
Table 68 Brazil cannabidiol market, by source type, 2018-2030 (USD Million)
Table 69 Brazil cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 70 Brazil cannabidiol market, by end use, 2018-2030 (USD Million)
Table 71 Mexico cannabidiol market, by source type, 2018-2030 (USD Million)
Table 72 Mexico cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 73 Mexico cannabidiol market, by end use, 2018-2030 (USD Million)
Table 74 Argentina cannabidiol market, by source type, 2018-2030 (USD Million)
Table 75 Argentina cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 76 Argentina cannabidiol market, by end use, 2018-2030 (USD Million)
Table 77 Colombia cannabidiol market, by source type, 2018-2030 (USD Million)
Table 78 Colombia cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 79 Colombia cannabidiol market, by end use, 2018-2030 (USD Million)
Table 80 Uruguay cannabidiol market, by source type, 2018-2030 (USD Million)
Table 81 Uruguay cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 82 Uruguay cannabidiol market, by end use, 2018-2030 (USD Million)
Table 83 Chile cannabidiol market, by source type, 2018-2030 (USD Million)
Table 84 Chile cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 85 Chile cannabidiol market, by end use, 2018-2030 (USD Million)
Table 86 MEA cannabidiol market, by region, 2018-2030 (USD Million)
Table 87 MEA cannabidiol market, by source type, 2018-2030 (USD Million)
Table 88 MEA cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 89 MEA cannabidiol market, by end use, 2018-2030 (USD Million)
Table 90 South Africa cannabidiol market, by source type, 2018-2030 (USD Million)
Table 91 South Africa cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 92 South Africa cannabidiol market, by end use, 2018-2030 (USD Million)
Table 93 Israel cannabidiol market, by source type, 2018-2030 (USD Million)
Table 94 Israel cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 95 Israel cannabidiol market, by end use, 2018-2030 (USD Million)
Table 2 North America cannabidiol market, by region, 2018-2030 (USD Million)
Table 3 North America cannabidiol market, by source type, 2018-2030 (USD Million)
Table 4 North America cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 5 North America cannabidiol market, by end use, 2018-2030 (USD Million)
Table 6 U.S. cannabidiol market, by source type, 2018-2030 (USD Million)
Table 7 U.S. cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 8 U.S. cannabidiol market, by end use, 2018-2030 (USD Million)
Table 9 Canada cannabidiol market, by source type, 2018-2030 (USD Million)
Table 10 Canada cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 11 Canada cannabidiol market, by end use, 2018-2030 (USD Million)
Table 12 Europe cannabidiol market, by region, 2018-2030 (USD Million)
Table 13 Europe cannabidiol market, by source type, 2018-2030 (USD Million)
Table 14 Europe cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 15 Europe cannabidiol market, by end use, 2018-2030 (USD Million)
Table 16 Germany cannabidiol market, by source type, 2018-2030 (USD Million)
Table 17 Germany cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 18 Germany cannabidiol market, by end use, 2018-2030 (USD Million)
Table 19 UK cannabidiol market, by source type, 2018-2030 (USD Million)
Table 20 UK cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 21 UK cannabidiol market, by end use, 2018-2030 (USD Million)
Table 22 France cannabidiol market, by source type, 2018-2030 (USD Million)
Table 23 France cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 24 France cannabidiol market, by end use, 2018-2030 (USD Million)
Table 25 Italy cannabidiol market, by source type, 2018-2030 (USD Million)
Table 26 Italy cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 27 Italy cannabidiol market, by end use, 2018-2030 (USD Million)
Table 28 Switzerland cannabidiol market, by source type, 2018-2030 (USD Million)
Table 29 Switzerland cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 30 Switzerland cannabidiol market, by end use, 2018-2030 (USD Million)
Table 31 Poland cannabidiol market, by source type, 2018-2030 (USD Million)
Table 32 Poland cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 33 Poland cannabidiol market, by end use, 2018-2030 (USD Million)
Table 34 The Netherlands cannabidiol market, by source type, 2018-2030 (USD Million)
Table 35 The Netherlands cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 36 The Netherlands cannabidiol market, by end use, 2018-2030 (USD Million)
Table 37 Czech Republic cannabidiol market, by source type, 2018-2030 (USD Million)
Table 38 Czech Republic cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 39 Czech Republic cannabidiol market, by end use, 2018-2030 (USD Million)
Table 40 Croatia cannabidiol market, by source type, 2018-2030 (USD Million)
Table 41 Croatia cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 42 Croatia cannabidiol market, by end use, 2018-2030 (USD Million)
Table 43 Asia-Pacific cannabidiol market, by region, 2018-2030 (USD Million)
Table 44 Asia-Pacific cannabidiol market, by source type, 2018-2030 (USD Million)
Table 45 Asia-Pacific cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 46 Asia-Pacific cannabidiol market, by end use, 2018-2030 (USD Million)
Table 47 China cannabidiol market, by source type, 2018-2030 (USD Million)
Table 48 China cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 49 China cannabidiol market, by end use, 2018-2030 (USD Million)
Table 50 Japan cannabidiol market, by source type, 2018-2030 (USD Million)
Table 51 Japan cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 52 Japan cannabidiol market, by end use, 2018-2030 (USD Million)
Table 53 India cannabidiol market, by source type, 2018-2030 (USD Million)
Table 54 India cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 55 India cannabidiol market, by end use, 2018-2030 (USD Million)
Table 56 South Korea cannabidiol market, by source type, 2018-2030 (USD Million)
Table 57 South Korea cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 58 South Korea cannabidiol market, by end use, 2018-2030 (USD Million)
Table 59 Australia cannabidiol market, by source type, 2018-2030 (USD Million)
Table 60 Australia cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 61 Australia cannabidiol market, by end use, 2018-2030 (USD Million)
Table 62 New Zealand cannabidiol market, by source type, 2018-2030 (USD Million)
Table 63 New Zealand cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 64 New Zealand cannabidiol market, by end use, 2018-2030 (USD Million)
Table 65 Latin America cannabidiol market, by source type, 2018-2030 (USD Million)
Table 66 Latin America cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 67 Latin America cannabidiol market, by end use, 2018-2030 (USD Million)
Table 68 Brazil cannabidiol market, by source type, 2018-2030 (USD Million)
Table 69 Brazil cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 70 Brazil cannabidiol market, by end use, 2018-2030 (USD Million)
Table 71 Mexico cannabidiol market, by source type, 2018-2030 (USD Million)
Table 72 Mexico cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 73 Mexico cannabidiol market, by end use, 2018-2030 (USD Million)
Table 74 Argentina cannabidiol market, by source type, 2018-2030 (USD Million)
Table 75 Argentina cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 76 Argentina cannabidiol market, by end use, 2018-2030 (USD Million)
Table 77 Colombia cannabidiol market, by source type, 2018-2030 (USD Million)
Table 78 Colombia cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 79 Colombia cannabidiol market, by end use, 2018-2030 (USD Million)
Table 80 Uruguay cannabidiol market, by source type, 2018-2030 (USD Million)
Table 81 Uruguay cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 82 Uruguay cannabidiol market, by end use, 2018-2030 (USD Million)
Table 83 Chile cannabidiol market, by source type, 2018-2030 (USD Million)
Table 84 Chile cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 85 Chile cannabidiol market, by end use, 2018-2030 (USD Million)
Table 86 MEA cannabidiol market, by region, 2018-2030 (USD Million)
Table 87 MEA cannabidiol market, by source type, 2018-2030 (USD Million)
Table 88 MEA cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 89 MEA cannabidiol market, by end use, 2018-2030 (USD Million)
Table 90 South Africa cannabidiol market, by source type, 2018-2030 (USD Million)
Table 91 South Africa cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 92 South Africa cannabidiol market, by end use, 2018-2030 (USD Million)
Table 93 Israel cannabidiol market, by source type, 2018-2030 (USD Million)
Table 94 Israel cannabidiol market, by sales type, 2018-2030 (USD Million)
Table 95 Israel cannabidiol market, by end use, 2018-2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Cannabidiol market: market outlook
Fig. 9 Cannabidiol competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Cannabidiol market driver impact
Fig. 15 Cannabidiol market restraint impact
Fig. 16 Cannabidiol market strategic initiatives analysis
Fig. 17 Cannabidiol market: Source type movement analysis
Fig. 18 Cannabidiol market: Source type outlook and key takeaways
Fig. 19 Hemp market estimates and forecast, 2018-2030
Fig. 20 Marijuana market estimates and forecast, 2018-2030
Fig. 21 Cannabidiol Market: Sales type movement Analysis
Fig. 22 Cannabidiol market: Sales type outlook and key takeaways
Fig. 23 Business to Business (B2B) market estimates and forecasts, 2018-2030
Fig. 24 Business to Business (B2C) market estimates and forecasts,2018-2030
Fig. 25 Hospital pharmacies market estimates and forecasts,2018-2030
Fig. 26 Online stores market estimates and forecasts,2018-2030
Fig. 27 Retail pharmacies market estimates and forecasts,2018-2030
Fig. 28 Cannabidiol market: end use movement analysis
Fig. 29 Cannabidiol market: end use outlook and key takeaways
Fig. 30 Medical use market estimates and forecasts, 2018-2030
Fig. 31 Chronic pain market estimates and forecasts,2018-2030
Fig. 32 Mental disorders market estimates and forecasts, 2018-2030
Fig. 33 Cancer market estimates and forecasts,2018-2030
Fig. 34 Others market estimates and forecasts, 2018-2030
Fig. 35 Personal use market estimates and forecasts,2018-2030
Fig. 36 Pharmaceutical CBD market estimates and forecasts,2018-2030
Fig. 37 Wellness market estimates and forecasts,2018-2030
Fig. 38 Food & beverages market estimates and forecasts,2018-2030
Fig. 39 Personal care & cosmetics market estimates and forecasts,2018-2030
Fig. 40 Nutraceuticals market estimates and forecasts,2018-2030
Fig. 41 Others end use market estimates and forecasts,2018-2030
Fig. 42 Global cannabidiol market: Regional movement analysis
Fig. 43 Global cannabidiol market: Regional outlook and key takeaways
Fig. 44 North America market estimates and forecasts, 2018-2030
Fig. 45 U.S. market estimates and forecasts, 2018-2030
Fig. 46 Canada market estimates and forecasts, 2018-2030
Fig. 47 Europe market estimates and forecasts, 2018-2030
Fig. 48 UK market estimates and forecasts, 2018-2030
Fig. 49 Germany market estimates and forecasts, 2018-2030
Fig. 50 France market estimates and forecasts, 2018-2030
Fig. 51 Italy market estimates and forecasts, 2018-2030
Fig. 52 Switzerland market estimates and forecasts, 2018-2030
Fig. 53 Poland market estimates and forecasts, 2018-2030
Fig. 54 Czech Republic market estimates and forecasts, 2018-2030
Fig. 55 Croatia market estimates and forecasts, 2018-2030
Fig. 56 Asia-Pacific market estimates and forecasts, 2018-2030
Fig. 57 China market estimates and forecasts, 2018-2030
Fig. 58 Japan market estimates and forecasts, 2018-2030
Fig. 59 India market estimates and forecasts, 2018-2030
Fig. 60 New Zealand market estimates and forecasts, 2018-2030
Fig. 61 South Korea market estimates and forecasts, 2018-2030
Fig. 62 Australia market estimates and forecasts, 2018-2030
Fig. 63 Latin America market estimates and forecasts, 2018-2030
Fig. 64 Brazil market estimates and forecasts, 2018-2030
Fig. 65 Mexico market estimates and forecasts, 2018-2030
Fig. 66 Argentina market estimates and forecasts, 2018-2030
Fig. 67 Colombia market estimates and forecasts, 2018-2030
Fig. 68 Uruguay market estimates and forecasts, 2018-2030
Fig. 69 Chile market estimates and forecasts, 2018-2030
Fig. 70 Middle East and Africa market estimates and forecasts, 2018-2030
Fig. 71 South Africa market estimates and forecasts, 2018-2030
Fig. 72 Israel market estimates and forecasts, 2018-2030
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Cannabidiol market: market outlook
Fig. 9 Cannabidiol competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Cannabidiol market driver impact
Fig. 15 Cannabidiol market restraint impact
Fig. 16 Cannabidiol market strategic initiatives analysis
Fig. 17 Cannabidiol market: Source type movement analysis
Fig. 18 Cannabidiol market: Source type outlook and key takeaways
Fig. 19 Hemp market estimates and forecast, 2018-2030
Fig. 20 Marijuana market estimates and forecast, 2018-2030
Fig. 21 Cannabidiol Market: Sales type movement Analysis
Fig. 22 Cannabidiol market: Sales type outlook and key takeaways
Fig. 23 Business to Business (B2B) market estimates and forecasts, 2018-2030
Fig. 24 Business to Business (B2C) market estimates and forecasts,2018-2030
Fig. 25 Hospital pharmacies market estimates and forecasts,2018-2030
Fig. 26 Online stores market estimates and forecasts,2018-2030
Fig. 27 Retail pharmacies market estimates and forecasts,2018-2030
Fig. 28 Cannabidiol market: end use movement analysis
Fig. 29 Cannabidiol market: end use outlook and key takeaways
Fig. 30 Medical use market estimates and forecasts, 2018-2030
Fig. 31 Chronic pain market estimates and forecasts,2018-2030
Fig. 32 Mental disorders market estimates and forecasts, 2018-2030
Fig. 33 Cancer market estimates and forecasts,2018-2030
Fig. 34 Others market estimates and forecasts, 2018-2030
Fig. 35 Personal use market estimates and forecasts,2018-2030
Fig. 36 Pharmaceutical CBD market estimates and forecasts,2018-2030
Fig. 37 Wellness market estimates and forecasts,2018-2030
Fig. 38 Food & beverages market estimates and forecasts,2018-2030
Fig. 39 Personal care & cosmetics market estimates and forecasts,2018-2030
Fig. 40 Nutraceuticals market estimates and forecasts,2018-2030
Fig. 41 Others end use market estimates and forecasts,2018-2030
Fig. 42 Global cannabidiol market: Regional movement analysis
Fig. 43 Global cannabidiol market: Regional outlook and key takeaways
Fig. 44 North America market estimates and forecasts, 2018-2030
Fig. 45 U.S. market estimates and forecasts, 2018-2030
Fig. 46 Canada market estimates and forecasts, 2018-2030
Fig. 47 Europe market estimates and forecasts, 2018-2030
Fig. 48 UK market estimates and forecasts, 2018-2030
Fig. 49 Germany market estimates and forecasts, 2018-2030
Fig. 50 France market estimates and forecasts, 2018-2030
Fig. 51 Italy market estimates and forecasts, 2018-2030
Fig. 52 Switzerland market estimates and forecasts, 2018-2030
Fig. 53 Poland market estimates and forecasts, 2018-2030
Fig. 54 Czech Republic market estimates and forecasts, 2018-2030
Fig. 55 Croatia market estimates and forecasts, 2018-2030
Fig. 56 Asia-Pacific market estimates and forecasts, 2018-2030
Fig. 57 China market estimates and forecasts, 2018-2030
Fig. 58 Japan market estimates and forecasts, 2018-2030
Fig. 59 India market estimates and forecasts, 2018-2030
Fig. 60 New Zealand market estimates and forecasts, 2018-2030
Fig. 61 South Korea market estimates and forecasts, 2018-2030
Fig. 62 Australia market estimates and forecasts, 2018-2030
Fig. 63 Latin America market estimates and forecasts, 2018-2030
Fig. 64 Brazil market estimates and forecasts, 2018-2030
Fig. 65 Mexico market estimates and forecasts, 2018-2030
Fig. 66 Argentina market estimates and forecasts, 2018-2030
Fig. 67 Colombia market estimates and forecasts, 2018-2030
Fig. 68 Uruguay market estimates and forecasts, 2018-2030
Fig. 69 Chile market estimates and forecasts, 2018-2030
Fig. 70 Middle East and Africa market estimates and forecasts, 2018-2030
Fig. 71 South Africa market estimates and forecasts, 2018-2030
Fig. 72 Israel market estimates and forecasts, 2018-2030
Companies Mentioned
- ENDOCA
- Cannoid, LLC
- Medical Marijuana, Inc.
- Folium Europe B.V.
- Canopy Growth Corporation
- Elixinol
- NuLeaf Naturals, LLC
- Isodiol International, Inc.
- PharmaHemp
- The Cronos Group
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | January 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 7.71 Billion |
| Forecasted Market Value ( USD | $ 22.05 Billion |
| Compound Annual Growth Rate | 15.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
